HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sahil Inamdar Selected Research

Sahil Inamdar Research Topics

Disease

9Neoplasms (Cancer)
10/2023 - 01/2017
2Wounds and Injuries (Trauma)
01/2023 - 04/2022
2Inflammation (Inflammations)
01/2023 - 10/2021
2Arthritis (Polyarthritis)
11/2022 - 10/2021
2Rheumatoid Arthritis
11/2022 - 10/2021
1Melanoma (Melanoma, Malignant)
01/2023
1Sepsis (Septicemia)
01/2023
1Infections
12/2022
1Experimental Arthritis
11/2022
1Autoimmune Diseases (Autoimmune Disease)
10/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2021
1Hematologic Neoplasms (Hematological Malignancy)
03/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2021
1Immune System Diseases (Immune Disorders)
01/2020

Drug/Important Bio-Agent (IBA)

2Succinic Acid (Succinate)IBA
10/2023 - 01/2023
2Ketoglutaric Acids (Ketoglutaric Acid)IBA
01/2023 - 11/2022
2PolymersIBA
01/2023 - 01/2023
2PFK15IBA
01/2023 - 10/2021
1poly(ethylene succinate)IBA
01/2023
1Biocompatible Materials (Biomaterials)IBA
01/2023
1EmulsionsIBA
01/2023
1GlutaminaseIBA
01/2023
1PolyaminesIBA
01/2023
1SpermineIBA
01/2023
1VaccinesIBA
01/2023
1PyrazinamideFDA LinkGeneric
12/2022
1Methotrexate (Mexate)FDA LinkGeneric
11/2022
1AutoantigensIBA
10/2021
1AntigensIBA
10/2021
1Collagen Type II (Type II Collagen)IBA
10/2021
1CollagenIBA
10/2021
1Immune Checkpoint InhibitorsIBA
03/2021
1Chimeric Antigen ReceptorsIBA
03/2021
1Protons (Proton)IBA
01/2018

Therapy/Procedure

5Immunotherapy
10/2023 - 01/2020
3Radiotherapy
04/2022 - 01/2018
3Therapeutics
01/2022 - 01/2017
1Proton Therapy
01/2018
1Radiation Dosimeters
01/2018